Fatiha Nassir - Search Results

Year	Number of Results
2002	1
2003	3
2004	1
2005	1
2006	1
2007	1
2010	2
2011	1
2012	1
2013	2
2014	2
2015	1
2016	1
2018	2
2022	1
2024	0

1

NAFLD: Mechanisms, Treatments, and Biomarkers.

Nassir F. Nassir F. Biomolecules. 2022 Jun 13;12(6):824. doi: 10.3390/biom12060824. Biomolecules. 2022. PMID: 35740949 Free PMC article. Review.

2

Sirtuins and nonalcoholic fatty liver disease.

Nassir F, Ibdah JA. Nassir F, et al. World J Gastroenterol. 2016 Dec 14;22(46):10084-10092. doi: 10.3748/wjg.v22.i46.10084. World J Gastroenterol. 2016. PMID: 28028356 Free PMC article. Review.

3

Role of mitochondria in nonalcoholic fatty liver disease.

Nassir F, Ibdah JA. Nassir F, et al. Int J Mol Sci. 2014 May 15;15(5):8713-42. doi: 10.3390/ijms15058713. Int J Mol Sci. 2014. PMID: 24837835 Free PMC article. Review.

4

Role of mitochondria in alcoholic liver disease.

Nassir F, Ibdah JA. Nassir F, et al. World J Gastroenterol. 2014 Mar 7;20(9):2136-42. doi: 10.3748/wjg.v20.i9.2136. World J Gastroenterol. 2014. PMID: 24605012 Free PMC article. Review.

5

Non-Alcoholic Fatty Pancreas Disease (NAFPD): A Silent Spectator or the Fifth Component of Metabolic Syndrome? A Literature Review.

Romana BS, Chela H, Dailey FE, Nassir F, Tahan V. Romana BS, et al. Among authors: nassir f. Endocr Metab Immune Disord Drug Targets. 2018;18(6):547-554. doi: 10.2174/1871530318666180328111302. Endocr Metab Immune Disord Drug Targets. 2018. PMID: 29595117 Review.

6

Pathogenesis and Prevention of Hepatic Steatosis.

Nassir F, Rector RS, Hammoud GM, Ibdah JA. Nassir F, et al. Gastroenterol Hepatol (N Y). 2015 Mar;11(3):167-75. Gastroenterol Hepatol (N Y). 2015. PMID: 27099587 Free PMC article.

7

Regulation of mitochondrial trifunctional protein modulates nonalcoholic fatty liver disease in mice.

Nassir F, Arndt JJ, Johnson SA, Ibdah JA. Nassir F, et al. J Lipid Res. 2018 Jun;59(6):967-973. doi: 10.1194/jlr.M080952. Epub 2018 Mar 26. J Lipid Res. 2018. PMID: 29581157 Free PMC article.

8

CD36-dependent signaling mediates fatty acid-induced gut release of secretin and cholecystokinin.

Sundaresan S, Shahid R, Riehl TE, Chandra R, Nassir F, Stenson WF, Liddle RA, Abumrad NA. Sundaresan S, et al. Among authors: nassir f. FASEB J. 2013 Mar;27(3):1191-202. doi: 10.1096/fj.12-217703. Epub 2012 Dec 11. FASEB J. 2013. PMID: 23233532 Free PMC article.

9

Luminal lipid regulates CD36 levels and downstream signaling to stimulate chylomicron synthesis.

Tran TT, Poirier H, Clément L, Nassir F, Pelsers MM, Petit V, Degrace P, Monnot MC, Glatz JF, Abumrad NA, Besnard P, Niot I. Tran TT, et al. Among authors: nassir f. J Biol Chem. 2011 Jul 15;286(28):25201-10. doi: 10.1074/jbc.M111.233551. Epub 2011 May 24. J Biol Chem. 2011. PMID: 21610069 Free PMC article.

10

CD36 deletion reduces VLDL secretion, modulates liver prostaglandins, and exacerbates hepatic steatosis in ob/ob mice.

Nassir F, Adewole OL, Brunt EM, Abumrad NA. Nassir F, et al. J Lipid Res. 2013 Nov;54(11):2988-97. doi: 10.1194/jlr.M037812. Epub 2013 Aug 20. J Lipid Res. 2013. PMID: 23964120 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

20 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

20 results

Results by year